nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Ifosfamide—testicular cancer	0.139	0.231	CbGbCtD
Oxybutynin—CYP2C8—Ifosfamide—testicular cancer	0.134	0.222	CbGbCtD
Oxybutynin—CYP3A5—Etoposide—testicular cancer	0.0664	0.11	CbGbCtD
Oxybutynin—CYP2C8—Etoposide—testicular cancer	0.0638	0.106	CbGbCtD
Oxybutynin—CYP3A4—Ifosfamide—testicular cancer	0.0542	0.09	CbGbCtD
Oxybutynin—CYP2D6—Vinblastine—testicular cancer	0.0452	0.075	CbGbCtD
Oxybutynin—CYP3A4—Vinblastine—testicular cancer	0.0287	0.0477	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—testicular cancer	0.0278	0.0461	CbGbCtD
Oxybutynin—CYP3A4—Etoposide—testicular cancer	0.0259	0.043	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—testicular cancer	0.0177	0.0293	CbGbCtD
Oxybutynin—Decreased appetite—Etoposide—testicular cancer	0.000379	0.000952	CcSEcCtD
Oxybutynin—Diarrhoea—Ifosfamide—testicular cancer	0.000378	0.000949	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000376	0.000946	CcSEcCtD
Oxybutynin—Fatigue—Etoposide—testicular cancer	0.000376	0.000944	CcSEcCtD
Oxybutynin—Stomatitis—Epirubicin—testicular cancer	0.000373	0.000938	CcSEcCtD
Oxybutynin—Pain—Etoposide—testicular cancer	0.000373	0.000937	CcSEcCtD
Oxybutynin—Constipation—Etoposide—testicular cancer	0.000373	0.000937	CcSEcCtD
Oxybutynin—Conjunctivitis—Epirubicin—testicular cancer	0.000372	0.000936	CcSEcCtD
Oxybutynin—Urinary tract infection—Epirubicin—testicular cancer	0.000372	0.000936	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—testicular cancer	0.000372	0.000934	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000369	0.000929	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—testicular cancer	0.000367	0.000923	CcSEcCtD
Oxybutynin—Haematuria—Epirubicin—testicular cancer	0.000365	0.000918	CcSEcCtD
Oxybutynin—Dizziness—Ifosfamide—testicular cancer	0.000365	0.000917	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—testicular cancer	0.000365	0.000917	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—testicular cancer	0.000363	0.000912	CcSEcCtD
Oxybutynin—Epistaxis—Epirubicin—testicular cancer	0.000361	0.000908	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—testicular cancer	0.00036	0.000905	CcSEcCtD
Oxybutynin—Sinusitis—Epirubicin—testicular cancer	0.000359	0.000903	CcSEcCtD
Oxybutynin—Feeling abnormal—Etoposide—testicular cancer	0.000359	0.000903	CcSEcCtD
Oxybutynin—Nausea—Dactinomycin—testicular cancer	0.000358	0.000899	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Etoposide—testicular cancer	0.000356	0.000896	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—testicular cancer	0.000354	0.000891	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—testicular cancer	0.000354	0.000891	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—testicular cancer	0.000354	0.000891	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—testicular cancer	0.000354	0.00089	CcSEcCtD
Oxybutynin—Vomiting—Ifosfamide—testicular cancer	0.000351	0.000882	CcSEcCtD
Oxybutynin—Hypersensitivity—Cisplatin—testicular cancer	0.00035	0.000881	CcSEcCtD
Oxybutynin—Rash—Ifosfamide—testicular cancer	0.000348	0.000875	CcSEcCtD
Oxybutynin—Dermatitis—Ifosfamide—testicular cancer	0.000348	0.000874	CcSEcCtD
Oxybutynin—Urticaria—Etoposide—testicular cancer	0.000346	0.00087	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—testicular cancer	0.000345	0.000868	CcSEcCtD
Oxybutynin—Rhinitis—Epirubicin—testicular cancer	0.000345	0.000867	CcSEcCtD
Oxybutynin—Abdominal pain—Etoposide—testicular cancer	0.000345	0.000866	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—testicular cancer	0.000345	0.000866	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—testicular cancer	0.000345	0.000866	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—testicular cancer	0.000343	0.000863	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—testicular cancer	0.000343	0.000861	CcSEcCtD
Oxybutynin—Hypoaesthesia—Epirubicin—testicular cancer	0.000342	0.00086	CcSEcCtD
Oxybutynin—Asthenia—Cisplatin—testicular cancer	0.000341	0.000858	CcSEcCtD
Oxybutynin—Pharyngitis—Epirubicin—testicular cancer	0.000341	0.000858	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—testicular cancer	0.000341	0.000857	CcSEcCtD
Oxybutynin—Urinary tract disorder—Epirubicin—testicular cancer	0.00034	0.000854	CcSEcCtD
Oxybutynin—Oedema peripheral—Epirubicin—testicular cancer	0.000339	0.000851	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—testicular cancer	0.000338	0.000849	CcSEcCtD
Oxybutynin—Connective tissue disorder—Epirubicin—testicular cancer	0.000338	0.000849	CcSEcCtD
Oxybutynin—Urethral disorder—Epirubicin—testicular cancer	0.000337	0.000847	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—testicular cancer	0.000334	0.00084	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—testicular cancer	0.000333	0.000838	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—testicular cancer	0.000333	0.000836	CcSEcCtD
Oxybutynin—Visual impairment—Epirubicin—testicular cancer	0.000331	0.000833	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—testicular cancer	0.000331	0.000832	CcSEcCtD
Oxybutynin—Nausea—Ifosfamide—testicular cancer	0.000328	0.000824	CcSEcCtD
Oxybutynin—Diarrhoea—Cisplatin—testicular cancer	0.000325	0.000818	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—testicular cancer	0.000322	0.000809	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—testicular cancer	0.000321	0.000808	CcSEcCtD
Oxybutynin—Hypersensitivity—Etoposide—testicular cancer	0.000321	0.000807	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—testicular cancer	0.000321	0.000806	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—testicular cancer	0.00032	0.000804	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—testicular cancer	0.00032	0.000804	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—testicular cancer	0.000319	0.000802	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—testicular cancer	0.000319	0.000802	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—testicular cancer	0.000319	0.000802	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000317	0.000796	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—testicular cancer	0.000316	0.000794	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000314	0.00079	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—testicular cancer	0.000313	0.000788	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—testicular cancer	0.000313	0.000787	CcSEcCtD
Oxybutynin—Asthenia—Etoposide—testicular cancer	0.000313	0.000786	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000313	0.000786	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—testicular cancer	0.000312	0.000784	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—testicular cancer	0.000312	0.000784	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—testicular cancer	0.00031	0.000779	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—testicular cancer	0.000309	0.000778	CcSEcCtD
Oxybutynin—Pruritus—Etoposide—testicular cancer	0.000308	0.000775	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—testicular cancer	0.000307	0.000772	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—testicular cancer	0.000307	0.000771	CcSEcCtD
Oxybutynin—Vomiting—Cisplatin—testicular cancer	0.000302	0.00076	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—testicular cancer	0.000301	0.000758	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—testicular cancer	0.000301	0.000757	CcSEcCtD
Oxybutynin—Rash—Cisplatin—testicular cancer	0.0003	0.000754	CcSEcCtD
Oxybutynin—Dermatitis—Cisplatin—testicular cancer	0.0003	0.000753	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—testicular cancer	0.000299	0.000752	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—testicular cancer	0.000299	0.000752	CcSEcCtD
Oxybutynin—Diarrhoea—Etoposide—testicular cancer	0.000298	0.00075	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—testicular cancer	0.000297	0.000747	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—testicular cancer	0.000297	0.000746	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—testicular cancer	0.000297	0.000746	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—testicular cancer	0.000295	0.000742	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—testicular cancer	0.000295	0.000742	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—testicular cancer	0.000295	0.000741	CcSEcCtD
Oxybutynin—Tension—Epirubicin—testicular cancer	0.000294	0.000738	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—testicular cancer	0.000293	0.000737	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—testicular cancer	0.000291	0.000731	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—testicular cancer	0.00029	0.000728	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—testicular cancer	0.000289	0.000726	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—testicular cancer	0.000288	0.000725	CcSEcCtD
Oxybutynin—Dizziness—Etoposide—testicular cancer	0.000288	0.000724	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000287	0.000721	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—testicular cancer	0.000284	0.000714	CcSEcCtD
Oxybutynin—Nausea—Cisplatin—testicular cancer	0.000283	0.00071	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—testicular cancer	0.000282	0.000709	CcSEcCtD
Oxybutynin—Cough—Methotrexate—testicular cancer	0.000279	0.000702	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—testicular cancer	0.000279	0.000701	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—testicular cancer	0.000278	0.000698	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—testicular cancer	0.000277	0.000697	CcSEcCtD
Oxybutynin—Vomiting—Etoposide—testicular cancer	0.000277	0.000697	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—testicular cancer	0.000277	0.000696	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—testicular cancer	0.000277	0.000696	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—testicular cancer	0.000275	0.000691	CcSEcCtD
Oxybutynin—Rash—Etoposide—testicular cancer	0.000275	0.000691	CcSEcCtD
Oxybutynin—Dermatitis—Etoposide—testicular cancer	0.000275	0.00069	CcSEcCtD
Oxybutynin—Headache—Etoposide—testicular cancer	0.000273	0.000686	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—testicular cancer	0.000273	0.000686	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—testicular cancer	0.000272	0.000684	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—testicular cancer	0.000272	0.000684	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—testicular cancer	0.000272	0.000683	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—testicular cancer	0.000271	0.000682	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00027	0.00068	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—testicular cancer	0.00027	0.000679	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—testicular cancer	0.000269	0.000676	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—testicular cancer	0.000269	0.000676	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—testicular cancer	0.000268	0.000675	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—testicular cancer	0.000268	0.000673	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—testicular cancer	0.000265	0.000665	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—testicular cancer	0.000263	0.000662	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—testicular cancer	0.000263	0.000661	CcSEcCtD
Oxybutynin—Cough—Epirubicin—testicular cancer	0.000261	0.000657	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—testicular cancer	0.000261	0.000656	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—testicular cancer	0.000261	0.000656	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—testicular cancer	0.000259	0.000652	CcSEcCtD
Oxybutynin—Infection—Methotrexate—testicular cancer	0.000259	0.000652	CcSEcCtD
Oxybutynin—Nausea—Etoposide—testicular cancer	0.000259	0.000651	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—testicular cancer	0.000258	0.00065	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000257	0.000646	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—testicular cancer	0.000256	0.000643	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—testicular cancer	0.000255	0.000641	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—testicular cancer	0.000255	0.000641	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—testicular cancer	0.000255	0.00064	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—testicular cancer	0.000254	0.000638	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—testicular cancer	0.000254	0.000637	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000253	0.000636	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—testicular cancer	0.000252	0.000633	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—testicular cancer	0.00025	0.000628	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—testicular cancer	0.000249	0.000626	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—testicular cancer	0.000249	0.000625	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—testicular cancer	0.000248	0.000624	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—testicular cancer	0.000246	0.000619	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—testicular cancer	0.000245	0.000615	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—testicular cancer	0.000244	0.000614	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—testicular cancer	0.000244	0.000614	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—testicular cancer	0.000244	0.000613	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—testicular cancer	0.000243	0.000612	CcSEcCtD
Oxybutynin—Infection—Epirubicin—testicular cancer	0.000243	0.00061	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—testicular cancer	0.000242	0.000608	CcSEcCtD
Oxybutynin—Shock—Epirubicin—testicular cancer	0.00024	0.000604	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—testicular cancer	0.00024	0.000603	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—testicular cancer	0.00024	0.000602	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—testicular cancer	0.000239	0.000601	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—testicular cancer	0.000238	0.000599	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000238	0.000598	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—testicular cancer	0.000237	0.000596	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—testicular cancer	0.000236	0.000593	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—testicular cancer	0.000236	0.000593	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—testicular cancer	0.000236	0.000593	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—testicular cancer	0.000235	0.000591	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—testicular cancer	0.000234	0.000589	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000234	0.000589	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—testicular cancer	0.000233	0.000586	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—testicular cancer	0.000233	0.000585	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—testicular cancer	0.000232	0.000583	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—testicular cancer	0.000231	0.00058	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—testicular cancer	0.00023	0.000578	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—testicular cancer	0.000228	0.000574	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—testicular cancer	0.000228	0.000573	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—testicular cancer	0.000227	0.00057	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—testicular cancer	0.000226	0.000568	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000226	0.000568	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000225	0.000566	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—testicular cancer	0.000225	0.000566	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—testicular cancer	0.000225	0.000564	CcSEcCtD
Oxybutynin—Pain—Methotrexate—testicular cancer	0.000223	0.000561	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000223	0.000559	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—testicular cancer	0.000222	0.000559	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—testicular cancer	0.000222	0.000557	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—testicular cancer	0.000221	0.000555	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—testicular cancer	0.000221	0.000555	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—testicular cancer	0.00022	0.000552	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—testicular cancer	0.000219	0.000551	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—testicular cancer	0.000217	0.000546	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—testicular cancer	0.000215	0.000542	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—testicular cancer	0.000215	0.000541	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—testicular cancer	0.000215	0.000541	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000213	0.000537	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—testicular cancer	0.000212	0.000534	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—testicular cancer	0.000211	0.000531	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000211	0.00053	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—testicular cancer	0.000211	0.000529	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—testicular cancer	0.000209	0.000525	CcSEcCtD
Oxybutynin—Pain—Epirubicin—testicular cancer	0.000209	0.000525	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—testicular cancer	0.000207	0.000521	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—testicular cancer	0.000206	0.000519	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000206	0.000518	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—testicular cancer	0.000204	0.000514	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—testicular cancer	0.000203	0.00051	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—testicular cancer	0.000201	0.000506	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—testicular cancer	0.000201	0.000505	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—testicular cancer	0.0002	0.000502	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—testicular cancer	0.000199	0.0005	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—testicular cancer	0.000196	0.000494	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000195	0.000491	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—testicular cancer	0.000195	0.00049	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—testicular cancer	0.000194	0.000488	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—testicular cancer	0.000193	0.000486	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—testicular cancer	0.000193	0.000486	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—testicular cancer	0.000193	0.000485	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—testicular cancer	0.000192	0.000483	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—testicular cancer	0.000187	0.000471	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—testicular cancer	0.000186	0.000468	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000185	0.000465	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—testicular cancer	0.000185	0.000464	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—testicular cancer	0.00018	0.000452	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—testicular cancer	0.00018	0.000451	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—testicular cancer	0.000179	0.000449	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—testicular cancer	0.000179	0.000449	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—testicular cancer	0.000175	0.000441	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—testicular cancer	0.000173	0.000434	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—testicular cancer	0.000173	0.000434	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—testicular cancer	0.000167	0.00042	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—testicular cancer	0.000167	0.000419	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—testicular cancer	0.000166	0.000417	CcSEcCtD
Oxybutynin—Rash—Methotrexate—testicular cancer	0.000165	0.000414	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—testicular cancer	0.000164	0.000413	CcSEcCtD
Oxybutynin—Headache—Methotrexate—testicular cancer	0.000164	0.000411	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—testicular cancer	0.000162	0.000408	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—testicular cancer	0.000162	0.000406	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—testicular cancer	0.00016	0.000402	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—testicular cancer	0.000155	0.00039	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—testicular cancer	0.000155	0.00039	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—testicular cancer	0.000155	0.000389	CcSEcCtD
Oxybutynin—Rash—Epirubicin—testicular cancer	0.000154	0.000387	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—testicular cancer	0.000154	0.000387	CcSEcCtD
Oxybutynin—Headache—Epirubicin—testicular cancer	0.000153	0.000385	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—testicular cancer	0.000149	0.000376	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—testicular cancer	0.000145	0.000365	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—testicular cancer	0.000144	0.000361	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—testicular cancer	0.000143	0.000358	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—testicular cancer	0.000142	0.000358	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—testicular cancer	0.000142	0.000356	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—testicular cancer	0.000134	0.000337	CcSEcCtD
